In the area of Transparency, KEI works on several different topics, including:
Continue Reading →
Using the U.S. Freedom of Information Act (FOIA), KEI has obtained the daily schedule of Ambassador Kirk, from March 20 to May 1, 2009. KEI has separately asked the USTR to routinely as a matter of transparency post this information on the USTR web page.
The response to the follow is presented below in two pdf files:
March 20 to April 14, 2009
April 15 to May 1, 2009
Continue Reading →
KEI publishes datasets obtained via research and Freedom of Information Act requests via the following: KEI Collection on the Internet Archive DrugDatabase.Info
On March 23, 2023, three prostate cancer patients, Robert Sachs, Clare Love and Eric Sawyer, filed an administrative appeal of the NIH decision to reject petition that HHS use Federal rights in patents on Xtandi to address pricing discrimination against… Continue Reading →
November 10, 2021 Andrew Burke, Ph.D. Senior Technology Transfer Manager, NCI Technology Transfer Center, Email: andy.burke@nih.gov. Re: Prospective Grant of an Exclusive Patent License: Development and Commercialization of CRISPR-Engineered T Cell Therapies for the Treatment of Cancer to Neogene Therapeutics… Continue Reading →
On September 22, 2021, Knowledge Ecology International (KEI) obtained a copy of the $3.5 billion contract between the U.S. government and Pfizer to purchase 500 million doses of the Pfizer/BioNTech vaccine for international donation to low- and middle-income countries. The… Continue Reading →
A March 21, 2021 New York Times article on vaccine access discusses how a technology invented and owned by the National Institutes of Health (NIH) is necessary to make several COVID-19 vaccines. The invention mentioned by the Times, titled Prefusion… Continue Reading →
On September 29, 2020, Knowledge Ecology International (KEI) filed a lawsuit against the National Institutes of Health (NIH) regarding three Freedom of Information Act (FOIA) requests filed by KEI. The complaint filed by KEI requests injunctive, declaratory, and other appropriate… Continue Reading →
These are the KEI comments on the questions raised by the FDA in the 85 FR 33165 and 85 FR 33169 Federal Register notices. KEI-comments-FDAOrange Book-31aug2020 KEI comments to the FDA relating to the Approved Drug Products With Therapeutic Equivalence… Continue Reading →
Through a Freedom of Information Act (FOIA) request, Knowledge Ecology International (KEI) has obtained 311 pages of correspondence between officials from the Office of the US Trade Representative (USTR) and employees of the Motion Picture Association (MPA), the Recording Industry… Continue Reading →